http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112014013958-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
filingDate 2012-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6bf730a34da5a6ebf75dba895517312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_560279f4274879b92232f89b1ec10cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49509437873c6d89acadf4f5b40af9a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a936f72f805662c7bebce123e8c2d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853f05bbdfc20b97043e65dd94fb5edb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ad12a49356fd89d8c8b2b9f520b4c4
publicationDate 2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112014013958-A2
titleOfInvention piperidinyl naphthylacetic acids
abstract Naphthylacetic Piperidinyl Acids The invention relates to the compounds of the formula (I): and their pharmaceutically acceptable salts, wherein R1, R2, R3 and X are defined in the detailed description and in the claims. furthermore, the present invention relates to methods of manufacture and use of the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds of formula I are antagonists or partial agonists at the crth2 receptor and may be useful in treating diseases and disorders associated with such a receptor, such as asthma.
priorityDate 2011-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426753052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16243949

Total number of triples: 32.